Frequently Asked Questions about Tectonic Therapeutic, Inc. (TECX)

Name: Tectonic Therapeutic, Inc. (TECX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Tectonic Therapeutic, Inc. (TECX) do?

Accepted Answer

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targe...

Question 2

Is Tectonic Therapeutic, Inc. (TECX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of TECX reveals an Altman Z-Score of 33.81 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if TECX fits their risk profile.

Question 3

What is the current P/E ratio for TECX?

Accepted Answer

As of the latest trading session, Tectonic Therapeutic, Inc. (TECX) has a trailing P/E ratio of -7.41.

Question 4

Who is the CEO of Tectonic Therapeutic, Inc.?

Accepted Answer

The current Chief Executive Officer of Tectonic Therapeutic, Inc. is Alise S. Reicin.

Question 5

What was TECX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Tectonic Therapeutic, Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does TECX pay a dividend?

Accepted Answer

Tectonic Therapeutic, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does TECX have?

Accepted Answer

In its latest reporting period, Tectonic Therapeutic, Inc. generated $-0.06B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Tectonic Therapeutic, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Tectonic Therapeutic, Inc. (TECX) is currently 2.19.

Question 9

What is the Price-to-Sales (P/S) ratio of TECX?

Accepted Answer

Based on trailing twelve-month data, Tectonic Therapeutic, Inc. (TECX) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Tectonic Therapeutic, Inc.'s Return on Equity (ROE)?

Accepted Answer

Tectonic Therapeutic, Inc. (TECX) has a Return on Equity (ROE) of -26.87%, representing its profitability relative to shareholder equity.

Period	Op. Income	Net Income	EPS
2025-12	-84M	-74.2M	-4.05
2024-12	-58M	-58M	-3.93
2023-12	-44.6M	-42.8M	-11.59
2022-12	-32.8M	-32.2M	-29.05
2021-12	-15.6M	-8.9M	-33.36

Period	Op. Income	Net Income	EPS
2025-12	-84M	-74.2M	-4.05
2024-12	-58M	-58M	-3.93
2023-12	-44.6M	-42.8M	-11.59
2022-12	-32.8M	-32.2M	-29.05
2021-12	-15.6M	-8.9M	-33.36